Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar CaptainFiveBaggr (96.92) Submitted: 10/13/2009 1:41:42 PM : Outperform Start Price: $3.39 ALXA Score: -138.61

Time to double down on Alexza

Featured Broker Partners


Advertisement